Epigral's revenue increased 16.6% YoY
  • 05 May 2026
  • Epigral Ltd reported a 22.1% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.6%.
  • Its expenses for the quarter were up by 14.0% QoQ and 25.0% YoY.
  • The net profit increased 107.0% QoQ and decreased 6.8% YoY.
  • The earnings per share (EPS) of Epigral Ltd stood at 18.76 during Q4 FY 2025-26.

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Epigral Ltd is a company operating in a specific industry, which is not specified in the available data. The main products or services offered by Epigral Ltd are also not detailed in the provided information. Additionally, there are no recent major developments related to the company that are mentioned in the data. Without further information, it is not possible to provide a detailed overview of the company's operations or industry context.

In the fourth quarter of fiscal year 2026 (Q4FY26), Epigral Ltd reported a total income of ₹735.59 crores, which marked a significant increase of 22.1% from the previous quarter (Q3FY26) where total income was ₹602.68 crores. Compared to the same quarter in the previous year (Q4FY25), the total income showed an increase of 16.6%, rising from ₹631.03 crores. This growth in revenue on both a quarter-over-quarter (QoQ) and year-over-year (YoY) basis is a notable aspect of the company's financial performance for the period.

During Q4FY26, Epigral Ltd achieved a profit before tax of ₹110.52 crores, reflecting a substantial increase of 102.4% compared to Q3FY26, where the profit before tax was ₹54.60 crores. However, when compared to Q4FY25, the profit before tax showed a decline of 15.7% from ₹131.06 crores. The company's tax expense for Q4FY26 was ₹28.59 crores, which is an 85.0% increase from the previous quarter and a 35.7% decrease from the same quarter last year. As a result, the profit after tax stood at ₹80.95 crores for Q4FY26, which was 107.0% higher than Q3FY26, but 6.8% lower than Q4FY25. The earnings per share (EPS) for the quarter was ₹18.76, showing a 106.8% improvement from the previous quarter, but a 6.9% decrease from the same quarter in the prior year.

Epigral Ltd's total expenses in Q4FY26 were ₹625.07 crores, an increase of 14.0% from Q3FY26, where the expenses were ₹548.08 crores. Compared to Q4FY25, total expenses rose by 25.0%, up from ₹499.97 crores. This increase in expenses indicates a trend of rising operational costs during the current fiscal period. The company's financial data does not provide information on other operating metrics such as the debt-to-equity ratio, current ratio, or other liquidity or solvency measures, limiting the ability to conduct a comprehensive analysis of the operating metrics.

Epigral Ltd announced its Q4 FY 2025-26 results on 5 May, 2026.

Epigral Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.

Key highlights of Epigral Ltd Q4 FY 2025-26 results include:

  • Revenue: ₹735.59 crore
  • Net Profit: ₹80.95 crore
  • EBITDA: ₹168.01 crore
  • Year-over-Year Growth: 16.6%
  • Quarter-over-Quarter Growth: 22.1%

Epigral Ltd reported a net profit of ₹80.95 crore in Q4 FY 2025-26, reflecting a -6.8% year-over-year growth.

Epigral Ltd posted a revenue of ₹735.59 crore in Q4 FY 2025-26.